从瘤学临床试验中排除基于功能状态的患者
Nicole D Agaronnik1, Mary Linton B Peters2,3, Lisa I Iezzoni3,4
1Harvard Medical School, Boston, MA, USA.
Clinical trials (London, England)
|January 2, 2025
概括
由于严格的绩效状况标准,残疾人面临癌症临床试验的排除. 目前的试验通常使用比拟的FDA指南更具限制的资格,限制了这一群体的获取.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 健康 公平 卫生 公平
背景情况:
- 与没有残疾的人相比,残疾人患癌症 (不包括皮肤癌) 的比例更高.
- 美国食品和药物管理局 (FDA) 正考虑更新指南 (2024年),以减轻临床试验资格的绩效状况标准.
- 基于绩效状况和其他标准的残疾排除在临床试验中需要审查.
研究的目的:
- 调查残疾人被排除在瘤学临床试验之外的情况.
- 评估当前临床试验中的性能状态标准的限制性.
- 将试验资格标准与FDA指南草案进行比较.
主要方法:
- 在ClinicalTrials.gov (2019-2023) 上列出的96个干预性瘤临床试验的第三期和第四期资格标准进行了审查.
- 使用东部合作性瘤学集团 (ECOG) 绩效状态尺度和卡诺夫斯基绩效尺度 (KPS) 评估功能状态值.
- 对与功能障碍或残疾相关的标准进行了定性分析.
主要成果:
- 大约40%的试验具有限制性的ECOG (0-1) 或KPS (≥70) 值.
- 只有20%的试验包括ECOG 2或KPS 60的患者.
- 许多试验具有未指定的标准,可能会排除残疾人;没有注意到任何住宿条件.
结论:
- 瘤学试验经常排除具有比FDA指导方针草案建议的更具限制性的绩效状况得分的个体.
- 除了绩效状态之外,现有的试验标准也可能无意中排除残疾人.
- 调查结果提供了基线数据,以评估2024年潜在的FDA指南对未来试验中残疾人纳入问题的影响.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
211
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
